Taiwan FDA registration 502eeecad7716a23381d883bc5576020
RAMP Cardiac Controls
TW: 倫普心臟標記品管液
Taiwan·Risk Class 2·MD·RESPONSE BIOMEDICAL CORPORATION·Registered Oct 01, 2015 – Oct 01, 2025ExpiredRegistration details
- Analysis ID
- 502eeecad7716a23381d883bc5576020
- License Form
- Ministry of Health Medical Device Import No. 027699
- Customs Code
- DHA05602769904
Company information
- Manufacturer
- RESPONSE BIOMEDICAL CORPORATION
- Manufacturer Country
- Canada
- Authorized Representative
- RECHI CO., LTD.
Product details
- Intended Use
- This product is used in the RAMP platform as a quality control of in vitro diagnostic cardiac markers.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Oct 01, 2015
- Expiry Date
- Oct 01, 2025
About this record
Access comprehensive regulatory information for RAMP Cardiac Controls in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 502eeecad7716a23381d883bc5576020 and manufactured by RESPONSE BIOMEDICAL CORPORATION. The authorized representative in Taiwan is RECHI CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices